Vicente Polo1,2, Maria Satue3,4, Alicia Gavin1,2, Elisa Vilades1,2, Elvira Orduna1,2, Marta Cipres1,2, Javier Garcia-Campayo2,5, Mayte Navarro-Gil6, Jose M Larrosa1,2, Luis E Pablo1,2, Elena Garcia-Martin1,2. 1. Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain. 2. Aragon Health Research Institute (IIS Aragon, IACS), Zaragoza, Spain. 3. Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain. mariasatue@gmail.com. 4. Aragon Health Research Institute (IIS Aragon, IACS), Zaragoza, Spain. mariasatue@gmail.com. 5. Department of Psychiatry, Miguel Servet University Hospital, Zaragoza, Spain. 6. Department of Psychology and Sociology, Faculty of Social and Human Sciences, University of Zaragoza, Zaragoza, Spain.
Abstract
PURPOSE: To evaluate the ability of swept source optical coherence tomography (SS-OCT) to detect retinal changes in patients with bipolar disorder (BD). METHODS: Twenty-three patients with BD and 23 controls underwent retinal evaluation using SS deep range imaging (DRI) Triton OCT. Full retinal thickness, the ganglion cell layer (GCL), the retinal nerve fiber layer (RNFL), and choroidal thickness were evaluated with automated segmentation software. RESULTS: Patients with BD were shown to have significant thinning of the macular full retinal thickness in the center (p = 0.049), inner temporal (p = 0.045), inner nasal (p = 0.016), and inner inferior (p = 0.016) of the ETDRS areas. The macular GCL layer was reduced in patients compared with controls (average, p = 0.002; superior, p = 0.009; superonasal, p = 0.009; inferonasal, p = 0.003; and inferior, p = 0.009). Peripapillary reduction of full retinal thickness (average, p < 0.001; superotemporal, p < 0.001; superonasal, p = 0.003; nasal, p = 0.005; and inferotemporal, p = 0.033), GCL (nasal, p = 0.025), and RNFL thickness (average, p = 0.002; superotemporal, p < 0.001; and superonasal, p = 0.045) was observed in patients compared with controls. No significant differences were observed in choroidal thickness measurements. CONCLUSIONS: BD patients were shown to have quantifiable thinning of full retinal thickness and the GCL in the macular area, as well as a peripapillary reduction of the RNFL and GCL thickness. The analysis of the retinal sublayers with SS-OCT may be a useful indicator to show degeneration and monitor disease progression in bipolar disorder.
PURPOSE: To evaluate the ability of swept source optical coherence tomography (SS-OCT) to detect retinal changes in patients with bipolar disorder (BD). METHODS: Twenty-three patients with BD and 23 controls underwent retinal evaluation using SS deep range imaging (DRI) Triton OCT. Full retinal thickness, the ganglion cell layer (GCL), the retinal nerve fiber layer (RNFL), and choroidal thickness were evaluated with automated segmentation software. RESULTS:Patients with BD were shown to have significant thinning of the macular full retinal thickness in the center (p = 0.049), inner temporal (p = 0.045), inner nasal (p = 0.016), and inner inferior (p = 0.016) of the ETDRS areas. The macular GCL layer was reduced in patients compared with controls (average, p = 0.002; superior, p = 0.009; superonasal, p = 0.009; inferonasal, p = 0.003; and inferior, p = 0.009). Peripapillary reduction of full retinal thickness (average, p < 0.001; superotemporal, p < 0.001; superonasal, p = 0.003; nasal, p = 0.005; and inferotemporal, p = 0.033), GCL (nasal, p = 0.025), and RNFL thickness (average, p = 0.002; superotemporal, p < 0.001; and superonasal, p = 0.045) was observed in patients compared with controls. No significant differences were observed in choroidal thickness measurements. CONCLUSIONS: BD patients were shown to have quantifiable thinning of full retinal thickness and the GCL in the macular area, as well as a peripapillary reduction of the RNFL and GCL thickness. The analysis of the retinal sublayers with SS-OCT may be a useful indicator to show degeneration and monitor disease progression in bipolar disorder.
Authors: Raquel Herrero; Elena Garcia-Martin; Carmen Almarcegui; Jose R Ara; Diego Rodriguez-Mena; Jesus Martin; Sofia Otin; Maria Satue; Luis E Pablo; Francisco J Fernandez Journal: Invest Ophthalmol Vis Sci Date: 2012-12-17 Impact factor: 4.799
Authors: Faith Dickerson; Catherine R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Jennifer Schroeder; Robert H Yolken Journal: Psychiatr Serv Date: 2013-01 Impact factor: 3.084
Authors: M Satue; M Seral; S Otin; R Alarcia; R Herrero; M P Bambo; M I Fuertes; L E Pablo; E Garcia-Martin Journal: Br J Ophthalmol Date: 2013-11-25 Impact factor: 4.638
Authors: Julio J González-López; Gema Rebolleda; Marina Leal; Noelia Oblanca; Francisco J Muñoz-Negrete; Lucienne Costa-Frossard; José C Alvarez-Cermeño Journal: Biomed Res Int Date: 2014-09-18 Impact factor: 3.411
Authors: Deepthi Bannai; Paulo Lizano; Megan Kasetty; Olivia Lutz; Victor Zeng; Suraj Sarvode; Leo A Kim; Scot Hill; Carol Tamminga; Brett Clementz; Elliot Gershon; Godfrey Pearlson; John B Miller; Matcheri Keshavan Journal: Psychiatry Res Neuroimaging Date: 2020-02-29 Impact factor: 2.376
Authors: Chloe Y Li; Itika Garg; Paulo Lizano; John B Miller; Deepthi Bannai; Megan Kasetty; Raviv Katz; Iniya Adhan; Konstantinos A A Douglas; Jay C Wang; Leo A Kim; Matcheri Keshavan Journal: Clin Ophthalmol Date: 2022-07-28